Oct. 8 at 7:21 PM
>
$5 worth a look:
$STTK Insider buying signals confidence, SL-325 autoimmune therapy.
$UGRO Secured 12M in new cannabis contracts, positioning for strong growth with potential Florida market expansion.
$MODD FDA clearance of the MODD1 insulin pump sets the stage for growth in personalized metabolic therapy.
$ASRV Maintains dividends and focuses on regional growth.
$OSS Strengthened its defense sector presence with a contract from US S.O. Command for rugged AI solutions.
PHX is benefiting from record royalty volumes and a significant dividend increase.
GNSS continues to expand globally, securing critical contracts for its advanced emergency response systems.
DALN is driving innovation with a new voter engagement tool for the 2024 election, enhancing digital reach.
LNSR leads in ophthalmic devices, having surpassed one million cataract procedures with its cutting-edge laser systems.
LFMD is expanding telehealth offerings, especially in weight management, with rising demand for GLP-1 therapies.
